+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Discovery Technologies Market - Market Size & Forecasting to 2030

  • PDF Icon

    Report

  • 176 Pages
  • August 2021
  • Region: Global
  • Quince Market Insights
  • ID: 5447934
The study of the global drug discovery technologies market includes detailed summary, as well as market segmentation, market size, market position, competitive economy, regional and national market analysis, value chain, impact of COVID-19 on global market, trade policy, market strategies of key players, growth trends, opportunities, and optimization. In the COVID-19 period, the drug discovery technologies market was valued at USD 37,500.3 million in 2021, and it is expected to grow at a CAGR of 6.0% over the forecast period.

The factor driving market growth is the rapid technological advancements for drug discovery. Moreover, growing prevalence of chronic diseases is the leading factor supporting the high demand for drug discovery technologies.

Methodology:


The market evaluation is done using a bottom-up approach, which involves analysing hundreds of contracts and/or sales data from a variety of sources, such as financial statements, online and in-house databases, industry journals, and other statistical publications, as well as coordinating with leading industry experts. Regional market share statistics and corporate market share data are created using a bottom-up data analysis approach. These broad secondary data sources are combined with expertise from primary research, such as company interviews, to develop the projection, which is then highlighted in SWOT analysis. The analyst's background enables them to estimate growth rates on a year-by-year basis, resulting in a clear picture of the future over the forecast period and a clear judgement of future market possibilities.

Regional Analysis:


North America, Europe, Asia-Pacific, Middle East and Africa, and South America are the major regions in which the drug discovery technologies market is divided. The growing attention on health and increased government and corporate investment in healthcare are driving demand for drug discovery technology in North America. The governments of the United States and Canada have policies that encourage investors to invest in innovative drug research and development.

Market Segmentation:


For evaluating the micro and macroeconomic aspects that can affect the growth road map, the market research report covers market volume, market share, quantitative and qualitative analysis, and product growth trends study. The market has been segmented based on technology, application, end user, and region.

Key Points of this report:

  • Who are the major participants in the drug discovery technologies market industry on a worldwide scale? What are their product specifics, key players, and contact information?
  • For the drug discovery technologies market, what technology is used? What is the status of that technology's advancement?
  • What is the present state of the drug discovery technologies market? What is the level of market competition in this industry?

What is the report about?


The competitor data, such as market growth and alliances, is also tracked in the market research report. Analysis of prominent manufacturers', pricing patterns, and product portfolios allows newcomers to learn about the existing market conditions. The research also discusses the business economy's core perspective, countries with rapid growth, industry variances, and constraints.

What does this report Provide

  • Global market and submarket forecasts, with supporting analysis, for the years 2021 to 2030.
  • Analysis of game-changing technological trends and how they will shape the industry
  • SWOT analysis of the sector conclusions and suggestions for the market
  • Detailed Segmentation to help each stakeholder in market
  • 2500+ data points in 60+ tables with focus on historic demand, estimated demand, and demand forecast
  • Impact of COVID-19 on demand estimation & forecasts (2020 onward)
  • Separate analysis of each segment to understand market deviation due to Covid-19 from 2020 onwards
  • Coverage across 5 major regions: North America, Europe, Asia Pacific, Middle East & Africa, and South America
  • Country level demand of the 25+ major markets with key trends & factors influencing the same

The drug discovery technologies market report can assist government agencies, state insurance systems, private insurance companies, pharmacists and health-care staff, pharmaceutical industry, wholesalers, regulatory authorities etc.

Table of Contents

1. Market Abstract
2. Market Introduction
2.1. Market Scope
2.2. Key Definitions-Content
2.2.1. Drug Discovery
2.2.2. Assay
2.2.3. Genomics & Proteomics
2.2.4. Vaccine Adjuvants
2.2.5. Nanotechnology
2.2.6. Chronic Diseases
2.2.7. Ribonucleic Acid (Rna)
3. Research Practice
3.1. Research Practice
3.1.1. Supply Based Analysis
3.1.2. Demand Based Analysis
3.1.3. Global Level Analysis
3.1.4. Country Level Analysis
3.1.5. Triangulation
3.2. Primary Data
3.3. Secondary Data
3.4. Market Evaluation & Forecasting Methodology
3.5. Assumptions/ Limitations for the Study
3.6. What this Study Provides
3.7. Key Questions Answered by this Report
3.8. This Study is Intended For
4. Key Related Data
4.1. Key Industry Trends
4.1.1. Growing Throughput of Major Technologies
4.1.2. Label-Free Technologies
4.1.3. Innovative and Emerging Treatments
4.1.4. Advancements in Pharmacogenomics Technologies
4.1.5. Next Generation Sequencing
4.2. Technological Advancements
4.2.1. Artificial Inteligence
4.2.2. Mixed Reality (Mr), Vr (Virtual Reality), and Augmented Reality (Ar)
4.2.3. New Drug Strategies
4.2.4. Crispr (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas9
4.2.5. Cryo- Em (Electron Microscopy) Technique
4.3. Guidelines & Regulations
4.3.1. U.S. Food and Drug Administration Amendments Act (Fdaaa) of 2007
4.3.2. U.S. Food and Drug Administration Safety Act and Innovation Act (Fdasia)
4.3.3. (Europe) Ich Q8 (R2) Pharmaceutical Development
4.3.4. (Europe) Ich Q9 Quality Risk Management
4.4. Covid- 19 Impact on Drug Discovery Technologies Market
5. Impact Factor Analysis
5.1. Market Dynamics
5.2. Drivers/Restraints/Opportunities/Challenges
5.2.1. Drivers
5.2.1.1. Increasing Burden of Diseases
5.2.2. Restraints
5.2.2.1. Ethical & Cost Issues in Clinical Development of Novel Drugs
5.2.3. Opportunities
5.2.3.1. Technological Advances in Biotechnology
5.2.4. Challenges
5.2.4.1. Long Duration of Clinical Trails
5.3. Porter's Five Forces Model
5.3.1. Threat of New Entrants: (Moderate)
5.3.2. Bargaining Power of Buyers: (Moderate)
5.3.3. Bargaining Power of Suppliers: (Moderate)
5.3.4. Intensity of Rivalry: (Moderate)
5.3.5. Threat of Substitutes: (Low to Moderate)
5.4. Supply Chain Analysis
6. Market Development Analysis
6.1. Overview
6.2. New Product Development (2015-2021)
6.3. Partnerships/Agreements/Collaborations/ Expansion (2015-2021)
6.4. Mergers & Acquisitions (2015-2021)
7. Drug Discovery Technologies Market, by Technology
7.1. Introduction
7.2. High Throughput Screening
7.2.1. High Throughput Screening, by Type
7.2.1.1. Robotics & Automation
7.2.1.2. Cell Based Assays:
7.2.1.3. Miniaturization:
7.2.1.4. High Content Screening:
7.2.1.5. Ultra-High Throughput Screening:
7.3. Genomics
7.3.1. Genomics, by Type
7.3.1.1. Functional Genomics
7.3.1.2. Structural Genomics
7.4. Nanotechnology
7.4.1. Nanotechnology, by Type
7.4.1.1. Atomic Force Microscopy
7.4.1.2. Nano Mass Spectroscopy
7.4.1.3. Dip Pen Nanolithography
7.5. Bioinformatics
7.6. Combinational Chemistry
7.7. Pharmacogenomics
7.8. Biochips
7.8.1. Biochips, by Type
7.8.1.1. Dna Microarrays
7.8.1.2. Lab-On-A-Chip
7.8.1.3. Proteomics Microarrays
7.9. Bioanalytical Instruments
7.9.1. Bioanalytical Instruments, by Type
7.9.1.1. Mass Spectrometry
7.9.1.2. Nuclear Magnetic Resonance (Nmr)
7.9.1.3. Micro Plate Readers
7.9.1.4. Chemotherapy Instruments
7.10. Ribonucleic Acid Interface (Rnai)
7.10.1. Ribonucleic Acid Interface (Rnai), by Type
7.10.1.1. Sirna:
7.10.1.2. Mirna:
7.10.1.3. Ddrnai:
7.10.1.4. Short Hairpin Rnas:
8. Drug Discovery Technologies Market, by Application
8.1. Introduction
8.2. Cardiovascular Diseases (Cvd)
8.3. Parkinson's
8.4. Alzheimer's
8.5. Others
9. Drug Discovery Technologies Market, by End-user
9.1. Introduction
9.2. Biopharmaceutical Companies
9.3. Biotech Companies
9.4. Pharmaceutical Companies
9.5. Research Institutes
10. Drug Discovery Technologies Market, Regional Analysis
10.1. Introduction
10.2. North America
10.2.1. North America Drug Discovery Technologies Market - by Country
10.2.2. North America Drug Discovery Technologies Market - by Technology
10.2.3. North America Drug Discovery Technologies Market - by Application
10.2.4. North America Drug Discovery Technologies Market - by End-user
10.2.5. U.S.
10.2.6. Canada
10.2.7. Mexico
10.3. Europe
10.3.1. Europe Drug Discovery Technologies Market - by Country
10.3.2. Europe Drug Discovery Technologies Market - by Technology
10.3.3. Europe Drug Discovery Technologies Market - by Application
10.3.4. Europe Drug Discovery Technologies Market - by End-user
10.3.5. Germany
10.3.6. UK
10.3.7. France
10.3.8. Russia
10.3.9. Spain
10.3.10. Italy
10.3.11. Rest of Europe
10.4. Asia-Pacific
10.4.1. Asia-Pacific Drug Discovery Technologies Market - by Country
10.4.2. Asia-Pacific Drug Discovery Technologies Market - by Technology
10.4.3. Asia-Pacific Drug Discovery Technologies Market - by Application
10.4.4. Asia-Pacific Drug Discovery Technologies Market - by End-user
10.4.5. China
10.4.6. Japan
10.4.7. Australia
10.4.8. India
10.4.9. South Korea
10.4.10. Rest of Asia-Pacific
10.5. Middle East& Africa
10.5.1. Middle East & Africa Drug Discovery Technologies Market - by Country
10.5.2. Middle East & Africa Drug Discovery Technologies Market - by Technology
10.5.3. Middle East & Africa Drug Discovery Technologies Market - by Application
10.5.4. Middle East & Africa Drug Discovery Technologies Market - by End-user
10.5.5. Uae
10.5.6. Saudi Arabia
10.5.7. South Africa
10.5.8. Qatar
10.5.9. Rest of Middle East & Africa
10.6. South America
10.6.1. South America Drug Discovery Technologies Market - by Country
10.6.2. South America Drug Discovery Technologies Market - by Technology
10.6.3. South America Drug Discovery Technologies Market - by Application
10.6.4. South America Drug Discovery Technologies Market - by End-user
10.6.5. Brazil
10.6.6. Argentina
10.6.7. Rest of South America
11. Global Drug Discovery Technologies Market, Competitve Intelligence
11.1. Competitive Positioning
11.1.1. Product Positioning, by Technology
11.1.2. Product Positioning, by Application
11.1.3. Product Positioning, by End-user
11.1.4. Regional Reach Positioning
11.2. Major Investments in Last Five Years by Global Players
11.3. Competitor Benchmarking
11.4. Vendor Matrix
11.5. Market Estimated Share Analysis (%), 2020
11.6. Compititive Leadership Outlook
12. Company Profiles
12.1. Bio-Rad Laboratories, Inc.
12.1.1. Company Overview
12.1.2. Bio-Rad Laboratories, Inc.: Financial Overview
12.1.3. Bio-Rad Laboratories, Inc.: Product Overview
12.1.4. Bio-Rad Laboratories, Inc.: SWOT Analysis
12.1.5. Bio-Rad Laboratories, Inc.: Key Developments
12.2. Perkinelmer Inc.
12.2.1. Company Overview
12.2.2. Perkinelmer Inc.: Financial Overview
12.2.3. Perkinelmer Inc.: Product Overview
12.2.4. Perkinelmer Inc.: SWOT Analysis
12.2.5. Perkinelmer Inc.: Key Developments
12.3. Incyte
12.3.1. Company Overview
12.3.2. Incyte Financial Overview
12.3.3. Incyte: Product Overview
12.3.4. Incyte: SWOT Analysis
12.3.5. Incyte: Key Developments
12.4. Gyros Protein Technologies
12.4.1. Company Overview
12.4.2. Gyros Protein Technologies: Financial Overview
12.4.3. Gyros Protein Technologies: Product Overview
12.4.4. Gyros Protein Technologies: SWOT Analysis
12.4.5. Gyros Protein Technologies: Key Developments
12.5. Evotec
12.5.1. Company Overview
12.5.2. Evotec: Financial Overview
12.5.3. Evotec: Product Overview
12.5.4. Evotec: SWOT Analysis
12.5.5. Evotec: Key Developments
12.6. Thermo Fisher Scientific Inc.
12.6.1. Company Overview
12.6.2. Thermo Fisher Scientific Inc.: Financial Overview
12.6.3. Thermo Fisher Scientific Inc.: Product Overview
12.6.4. Thermo Fisher Scientific Inc.: SWOT Analysis
12.6.5. Thermo Fisher Scientific Inc.: Key Development
12.7. Agilent Technologies, Inc.
12.7.1. Company Overview
12.7.2. Agilent Technologies, Inc.: Financial Overview
12.7.3. Agilent Technologies, Inc.: Product Overview
12.7.4. Agilent Technologies, Inc.: SWOT Analysis
12.7.5. Agilent Technologies, Inc.: Key Development
12.8. Astrazeneca
12.8.1. Company Overview
12.8.2. Astrazeneca: Financial Overview
12.8.3. Astrazeneca: Product Overview
12.8.4. Astrazeneca: SWOT Analysis
12.8.5. Astrazeneca: Key Developments
12.9. F.Hoffmann -La Roche Ltd.
12.9.1. Company Overview
12.9.2. F.Hoffmann La- Roche Ltd.: Financial Overview
12.9.3. F.Hoffmann La-Roche Ltd.: Product Overview
12.9.4. F.Hoffmann La-Roche Ltd.: SWOT Analysis
12.9.5. F.Hoffmann La- Roche Ltd.: Key Developments
12.10. Merck Kgaa
12.10.1. Company Overview
12.10.2. Merck Kgaa: Financial Overview
12.10.3. Merck Kgaa: Product Overview
12.10.4. Merck Kgaa: SWOT Analysis
12.10.5. Merck Kgaa: Key Development
12.11. Charles River Laboratories International Inc.
12.11.1. Company Overview
12.11.2. Charles River International Inc.: Financial Overview
12.11.3. Charles River International Inc.: Product Overview
12.11.4. Charles River International Inc.: SWOT Analysis
12.11.5. Charles River International Inc.: Key Developments
12.12. Tecan
12.12.1. Company Overview
12.12.2. Tecan.: Financial Overview
12.12.3. Tecan: Product Overview
12.12.4. Tecan: SWOT Analysis
12.12.5. Tecan: Key Developments
12.13. Shimadzu Corporation
12.13.1. Company Overview
12.13.2. Shimadzu Corporation: Financial Overview
12.13.3. Shimadzu Corporation: Product Overview
12.13.4. Shimadzu Corporation: SWOT Analysis
12.13.5. Shimadzu Corporation: Key Developments
12.14. Eurofins Scientific
12.14.1. Company Overview
12.14.2. Eurofins Scientific: Financial Overview
12.14.3. Eurofins Scientific: Product Overview
12.14.4. Eurofins Scietific: SWOT Analysis
12.14.5. Eurofins Scientific: Key Developments
12.15. Chembridge Corporation
12.15.1. Company Overview
12.15.2. Chembridge Corporation: Product Overview
12.15.3. Chembridge Corporation: SWOT Analysis
12.15.4. Chembridge Corporation.: Key Developments
13. Appendix
13.1. List of Abbreviation
13.2. Key Stakeholders’ Opinion
13.3. Key Related Reports
List of Tables
Table 1. New Product Development (2015-2021)
Table 2. Partnerships/Agreements/Collaborations/ Expansion (2015-2021)
Table 3. Mergers & Acquisitions (2015-2021)
Table 4. Drug Discovery Technologies Market, by Technology - Under Covid-19 (Usd Million) 2018-2030
Table 5. Drug Discovery Technologies Market, by Technology - (Usd Million) 2018-2030
Table 6. Drug Discovery Technologies for High Throughput Screening Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 7. Drug Discovery Technologies for High Throughput Screening Market, by Region (Usd Million) 2018-2030
Table 8. Drug Discovery Technologies Market for High Throughput Screening, by Type -Under Covid-19 (Usd Million) 2018-2030
Table 9. Drug Discovery Technologies Market for High Throughput Screening, by Type (Usd Million) 2018-2030
Table 10. Drug Discovery Technologies for Genomics Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 11. Drug Discovery Technologies for Genomics Market, by Region (Usd Million) 2018-2030
Table 12. Drug Discovery Technologies Market for Genomics, by Type -Under Covid-19 (Usd Million) 2018-2030
Table 13. Drug Discovery Technologies Market for Genomics, by Type (Usd Million) 2018-2030
Table 14. Drug Discovery Technologies for Nanotechnology Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 15. Drug Discovery Technologies for Nanotechnology Market, by Region (Usd Million) 2018-2030
Table 16. Drug Discovery Technologies Market for Nanotechnology, by Type -Under Covid-19 (Usd Million) 2018-2030
Table 17. Drug Discovery Technologies Market for Nanotechnology, by Type (Usd Million) 2018-2030
Table 18. Drug Discovery Technologies for Bioinformatics Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 19. Drug Discovery Technologies for Bioinformatics Market, by Region (Usd Million) 2018-2030
Table 20. Drug Discovery Technologies for Combinational Chemistry Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 21. Drug Discovery Technologies for Combinational Chemistry Market, by Region (Usd Million) 2018-2030
Table 22. Drug Discovery Technologies for Pharmacogenomics Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 23. Drug Discovery Technologies for Pharmacogenomics Market, by Region (Usd Million) 2018-2030
Table 24. Drug Discovery Technologies for Biochips Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 25. Drug Discovery Technologies for Biochips Market, by Region (Usd Million) 2018-2030
Table 26. Drug Discovery Technologies Market for Biochips, by Type -Under Covid-19 (Usd Million) 2018-2030
Table 27. Drug Discovery Technologies Market for Biochips, by Type (Usd Million) 2018-2030
Table 28. Drug Discovery Technologies for Bioanalytical Instruments Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 29. Drug Discovery Technologies for Bioanalytical Instruments Market, by Region (Usd Million) 2018-2030
Table 30. Drug Discovery Technologies Market for Bioanalytical Instruments, by Type -Under Covid-19 (Usd Million) 2018-2030
Table 31. Drug Discovery Technologies Market for Bioanalytical Instruments, by Type (Usd Million) 2018-2030
Table 32. Drug Discovery Technologies for Ribonucleic Acid Interface (Rnai) Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 33. Drug Discovery Technologies for Ribonucleic Acid Interface (Rnai) Market, by Region (Usd Million) 2018-2030
Table 34. Drug Discovery Technologies Market for Ribonucleic Acid Interface (Rnai), by Type -Under Covid-19 (Usd Million) 2018-2030
Table 35. Drug Discovery Technologies Market for Ribonucleic Acid Interface (Rnai), by Type (Usd Million) 2018-2030
Table 36. Drug Discovery Technologies Market, by Application - Under Covid-19(Usd Million) 2018-2030
Table 37. Drug Discovery Technologies Market, by Application - (Usd Million) 2018-2030
Table 38. Drug Discovery Technologies for Cardiovascular Diseases (Cvd) Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 39. Drug Discovery Technologies for Cardiovascular Diseases (Cvd) Market, by Region (Usd Million) 2018-2030
Table 40. Drug Discovery Technologies for Parkinson's Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 41. Drug Discovery Technologies for Parkinson's Market, by Region (Usd Million) 2018-2030
Table 42. Drug Discovery Technologies for Alzheimer's Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 43. Drug Discovery Technologies for Alzheimer's Market, by Region (Usd Million) 2018-2030
Table 44. Drug Discovery Technologies for Others Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 45. Drug Discovery Technologies for Others Market, by Region (Usd Million) 2018-2030
Table 46. Drug Discovery Technologies Market, by End-user - Under Covid-19 (Usd Million) 2018-2030
Table 47. Drug Discovery Technologies Market, by End-user - (Usd Million) 2018-2030
Table 48. Drug Discovery Technologies for Biopharmaceutical Companies Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 49. Drug Discovery Technologies for Biopharmaceutical Companies Market, by Region (Usd Million) 2018-2030
Table 50. Drug Discovery Technologies for Biotech Companies Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 51. Drug Discovery Technologies for Biotech Companies Market, by Region (Usd Million) 2018-2030
Table 52. Drug Discovery Technologies for Pharmaceutical Companies Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 53. Drug Discovery Technologies for Pharmaceutical Companies Market, by Region (Usd Million) 2018-2030
Table 54. Drug Discovery Technologies for Research Institutes Market, by Region -Under Covid-19 (Usd Million) 2018-2030
Table 55. Drug Discovery Technologies for Research Institutes Market, by Region (Usd Million) 2018-2030
Table 56. Drug Discovery Technologies Market, by Region- Under Covid-19 (Usd Million) 2018-2030
Table 57. Drug Discovery Technologies Market, by Region (Usd Million) 2018-2030
Table 58. North America Drug Discovery Technologies Market, by Country - Under Covid-19 (Usd Million) 2018-2030
Table 59. North America Drug Discovery Technologies Market, by Country (Usd Million) 2018-2030
Table 60. North America Drug Discovery Technologies Market, by Technology - Under Covid-19 (Usd Million) 2018-2030
Table 61. North America Drug Discovery Technologies Market, by Technology - (Usd Million) 2018-2030
Table 62. North America Drug Discovery Technologies Market, by Application - Under Covid-19(Usd Million) 2018-2030
Table 63. North America Drug Discovery Technologies Market, by Application - (Usd Million) 2018-2030
Table 64. North America Drug Discovery Technologies Market, by End-user - Under Covid-19 (Usd Million), 2018-2030
Table 65. North America Drug Discovery Technologies Market, by End-user - (Usd Million), 2018-2030
Table 66. Europe Drug Discovery Technologies Market, by Country - Under Covid-19 2018-2030 (Usd Million) 2018-2030
Table 67. Europe Drug Discovery Technologies Market, by Country (Usd Million) 2018-2030
Table 68. Europe Drug Discovery Technologies Market, by Technology - Under Covid-19 (Usd Million) 2018-2030
Table 69. Europe Drug Discovery Technologies Market, by Technology - (Usd Million) 2018-2030
Table 70. Europe Drug Discovery Technologies Market, by Application - Under Covid-19 (Usd Million) 2018-2030
Table 71. Europe Drug Discovery Technologies Market, by Application - (Usd Million) 2018-2030
Table 72. Europe Drug Discovery Technologies Market, by End-user - Under Covid-19 (Usd Million), 2018-2030
Table 73. Europe Drug Discovery Technologies Market, by End-user - (Usd Million), 2018-2030
Table 74. Asia-Pacific Drug Discovery Technologies Market, by Country -Under Covid-19 (Usd Million) 2018-2030
Table 75. Asia-Pacific Drug Discovery Technologies Market, by Country (Usd Million) 2018-2030
Table 76. Asia-Pacific Drug Discovery Technologies Market, by Technology - Under Covid-19 (Usd Million) 2018-2030
Table 77. Asia-Pacific Drug Discovery Technologies Market, by Technology - (Usd Million) 2018-2030
Table 78. Asia-Pacific Drug Discovery Technologies Market, by Application - Under Covid-19(Usd Million) 2018-2030
Table 79. Asia-Pacific Drug Discovery Technologies Market, by Application - (Usd Million) 2018-2030
Table 80. Asia-Pacific Drug Discovery Technologies Market, by End-user - Under Covid-19 (Usd Million), 2018-2030
Table 81. Asia-Pacific Drug Discovery Technologies Market, by End-user - (Usd Million), 2018-2030
Table 82. Middle East& Africa Drug Discovery Technologies Market, by Country-Under Covid-19(Usd Million) 2018-2030
Table 83. Middle East& Africa Drug Discovery Technologies Market, by Country (Usd Million) 2018-2030
Table 84. Middle East & Africa Drug Discovery Technologies Market, by Technology - Under Covid-19 (Usd Million) 2018-2030
Table 85. Middle East & Africa Drug Discovery Technologies Market, by Technology - (Usd Million) 2018-2030
Table 86. Middle East & Africa Drug Discovery Technologies Market, by Application - Under Covid-19(Usd Million) 2018-2030
Table 87. Middle East & Africa Drug Discovery Technologies Market, by Application - (Usd Million) 2018-2030
Table 88. Middle East & Africa Drug Discovery Technologies Market, by End-user - Under Covid-19 (Usd Million), 2018-2030
Table 89. Middle East & Africa Drug Discovery Technologies Market, by End-user - (Usd Million), 2018-2030
Table 90. South America Drug Discovery Technologies Market, by Country -Under Covid-19 (Usd Million) 2018-2030
Table 91. South America Drug Discovery Technologies Market, by Country (Usd Million) 2018-2030
Table 92. South America Drug Discovery Technologies Market, by Technology - Under Covid-19 (Usd Million) 2018-2030
Table 93. South America Drug Discovery Technologies Market, by Technology - (Usd Million) 2018-2030
Table 94. South America Drug Discovery Technologies Market, by Application - Under Covid-19(Usd Million) 2018-2030
Table 95. South America Drug Discovery Technologies Market, by Application - (Usd Million) 2018-2030
Table 96. South America Drug Discovery Technologies Market, by End-user - Under Covid-19 (Usd Million), 2018-2030
Table 97. South America Drug Discovery Technologies Market, by End-user - (Usd Million), 2018-2030
Table 98. Market Estimated Share Analysis, 2020
List of Figures
Figure 1. Drug Discovery Technologies Market: by Technology, 2021 & 2030
Figure 2. Drug Discovery Technologies Market: by Application, 2021 & 2030
Figure 3. Drug Discovery Technologies Market: by End-user, 2021 & 2030
Figure 4. Drug Discovery Technologies Market: by Region, 2018-2030
Figure 5. Drug Discovery Technologies Market - Market Scope
Figure 6. Drug Discovery Technologies Market -Research Practice
Figure 7. Drug Discovery Technologies Market -Research Methodology
Figure 8. Drug Discovery Technologies Market -Primary and Secondary Research
Figure 9. Droc Analysis
Figure 10. Porter's Five Forces Model- Drug Discovery Technologies Market
Figure 11. Supply Chain Analysis
Figure 12. Drug Discovery Technologies Market, by Technology, 2021 & 2030
Figure 13. Drug Discovery Technologies Market, by Application, 2021 & 2030
Figure 14. Drug Discovery Technologies Market, by End-user, 2021 & 2030
Figure 15. Drug Discovery Technologies Market - by Region
Figure 16. North America Drug Discovery Technologies Market Snapshot
Figure 17. North America Drug Discovery Technologies Market - by Country 2018-2030
Figure 18. North America Drug Discovery Technologies Market - by Technology, 2018-2030
Figure 19. North America Drug Discovery Technologies Market - by Application 2018-2030
Figure 20. North America Drug Discovery Technologies Market - by End-user 2018-2030
Figure 21. U.S. Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 22. Canada Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 23. Mexico Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 24. Europe Drug Discovery Technologies Market Snapshot
Figure 25. Europe Drug Discovery Technologies Market - by Country, 2018-2030
Figure 26. Europe Drug Discovery Technologies Market - by Technology, 2018-2030
Figure 27. Europe Drug Discovery Technologies Market - by Application 2018-2030
Figure 28. Europe Drug Discovery Technologies Market - by End-user 2018-2030
Figure 29. Germany Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 30. UK Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 31. France Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 32. Russia Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 33. Spain Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 34. Italy Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 35. Rest of Europe Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 36. Asia-Pacific Drug Discovery Technologies Market Snapshot
Figure 37. Asia-Pacific Drug Discovery Technologies Market - by Country ,2018-2030
Figure 38. Asia-Pacific Drug Discovery Technologies Market - by Technology, 2018-2030
Figure 39. Asia-Pacific Drug Discovery Technologies Market - by Application 2018-2030
Figure 40. Asia-Pacific Drug Discovery Technologies Market - by End-user 2018-2030
Figure 41. China Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 42. Japan Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 43. Australia Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 44. India Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 45. South Korea Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 46. Rest of Asia-Pacific Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 47. Middle East& Africa Drug Discovery Technologies Market Snapshot
Figure 48. Middle East & Africa Drug Discovery Technologies Market - by Country, 2018-2030
Figure 49. Middle East & Africa Drug Discovery Technologies Market - by Technology, 2018-2030
Figure 50. Middle East & Africa Drug Discovery Technologies Market - by Application 2018-2030
Figure 51. Middle East & Africa Drug Discovery Technologies Market - by End-user 2018-2030
Figure 52. Uae Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 53. Saudi Arabia Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 54. South Africa Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 55. Qatar Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 56. Rest of Middle East & Africa Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 57. South America Drug Discovery Technologies Market Snapshot
Figure 58. South America Drug Discovery Technologies Market - by Country, 2018-2030
Figure 59. South America Drug Discovery Technologies Market - by Technology, 2018-2030
Figure 60. South America Drug Discovery Technologies Market - by Application 2018-2030
Figure 61. South America Drug Discovery Technologies Market - by End-user 2018-2030
Figure 62. Brazil Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 63. Argentina Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 64. Rest of South America Drug Discovery Technologies Market Overview, 2021 & 2030
Figure 65. Product Positioning, by Technology
Figure 66. Product Positioning, by Application
Figure 67. Product Positioning, by End-user
Figure 68. Regional Reach Positioning
Figure 69. Vendor Matrix
Figure 70. Bio-Rad Laboratories, Inc. (Business Overview)
Figure 71. Bio-Rad Laboratories, Inc. (Financial Overview)
Figure 72. Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 73. Perkinelmer Inc. (Business Overview)
Figure 74. Perkinelmer Inc. (Financial Overview)
Figure 75. Perkinelmer Inc.: SWOT Analysis
Figure 76. Incyte (Business Overview)
Figure 77. Incyte (Financial Overview)
Figure 78. Incyte: SWOT Analysis
Figure 79. Gyros Protein Technologies (Business Overview)
Figure 80. Gyros Protein Technologies (Financial Overview)
Figure 81. Gyros Protein Technologies: SWOT Analysis
Figure 82. Evotec (Business Overview)
Figure 83. Evotec (Financial Overview)
Figure 84. Evotec: SWOT Analysis
Figure 85. Thermo Fisher Scientific Inc. (Business Overview)
Figure 86. Thermo Fisher Scientific Inc. (Financial Overview)
Figure 87. Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 88. Agilent Technologies, Inc. (Business Overview)
Figure 89. Agilent Technologies, Inc. (Financial Overview)
Figure 90. Agilent Technologies, Inc.: SWOT Analysis
Figure 91. Astrazeneca (Business Overview)
Figure 92. Astrazeneca (Financial Overview)
Figure 93. Astrazeneca: SWOT Analysis
Figure 94. F. Hoffmann- La Roche Ltd. (Business Overview)
Figure 95. F.Hoffmann La -Roche Ltd. (Financial Overview)
Figure 96. F. Hoffmann La -Roche Ltd.: SWOT Analysis
Figure 97. Merck Kgaa (Business Overview)
Figure 98. Merck Kgaa (Financial Overview)
Figure 99. Merck Kgaa: SWOT Analysis
Figure 100. Charles Laboratories International Inc. (Business Overview)
Figure 101. Charles River International Inc. (Financial Overview)
Figure 102. Charles River International Inc.: SWOT Analysis
Figure 103. Tecan (Business Overview)
Figure 104. Tecan (Financial Overview)
Figure 105. Tecan: SWOT Analysis
Figure 106. Shimadzu Corporation (Business Overview)
Figure 107. Shimadzu Corporation (Financial Overview)
Figure 108. Shimadzu Corporation: SWOT Analysis
Figure 109. Eurofins Scientific (Business Overview)
Figure 110. Eurofins Scientific (Financial Overview)
Figure 111. Eurofins Scientific: SWOT Analysis
Figure 112. Chembridge Corporation (Business Overview)
Figure 113. Chembridge Corporation.: SWOT Analysis

Executive Summary

The global drug discovery technologies market in the COVID-19 period has been estimated to value USD 37,500.3 million in 2021 and is projected to reach USD 63,285.3 million by 2030 with a CAGR of 6.0%. However, without the COVID-19 impact, the global drug discovery technologies market was estimated to be USD 37,514.9 million in 2021 and reach USD 62,505.1 million by 2030 with a CAGR of 5.8%.

Drug discovery technologies find applications in drug discovery to diagnose cardiovascular, oncology-related, neurological, and other diseases. Increasing prevalence of chronic diseases has led to the drug discovery technologies market growth. Companies operating in the drug discovery technologies market are focusing on improving treatments and therapies by offering superior technologies.

The pharmaceutical industry is adopting multiple approaches to drug discovery. Current drug discovery technologies use modern techniques like high throughput screening, bioinformatics, structural-based drug design, and others in drug development and discovery. Advancements in biochemical, translational, and molecular studies in biomedical research have led to the commercial development of new and effective drug discovery technologies. Collaborations and partnerships among researchers and the biopharmaceutical industry have led to the innovation of advanced technologies. Furthermore, growing drug discovery start-ups having various drug candidates in clinical trial stage is expected to boost the market growth. Also, adoption of artificial intelligence (AI) in drug discovery by existing companies is further fuelling the market growth.

The spread of coronavirus has resulted in tremendous pressure on the healthcare sector. The COVID-19 outbreak has thrown a spotlight on the need to develop medicines and increase disease detection and prevention efficiency around the world. Hence, the demand for drug discovery technologies has surged significantly, and the market is experiencing rapid growth.

Major players operating in this market include Thermofisher Scietific, Merck KGAA, Agilent, Astrazeneca, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., Perkinelmer, Incyte, Gyros Protein Technologies, Evotec, Chembridge, Charles River Laboratories, Tecan Trading AG, Shimadzu Corporation and Eurofins Discovery. However, the market is dominated by companies such as F. Hoffmann-La Roche Ltd, Thermofisher Scietific, Merck KGAA, Agilent and Astrazeneca among others. The dominance is due to their vast product portfolio in drug discovery technologies industry such as spectrometry instruments, micro plate readers, microarrays and the recent introduction of AI based softwares in drug discovery. Additionally, companies have adopted merger & acquition and collaboration as their main strategy. Such strategies have helped these companies in developing and launching numerous drugs and pharmaceutical products for tackling the increasing burden of diseases regionally. Also, the recent outbreak of COVID 19 pandemic have resulted in developing cost-effective vaccines in short period of times, there by creating many lucrative opportunities for major players operating in the market.

The drug discovery technologies market has been segmented based on technology, application, end user, and region.

Based on the technology, the market is segmented into bioanalytical instruments, biochips, bioinformatics, combinatorial chemistry, genomics, high throughput screening, nanotechnology, pharmacogenomics, and ribonucleic acid interface. The high throughput screening segment is accounted to hold the largest share in the global drug discovery technologies market during the forecast period. High throughput screening segment in the COVID-19 period has been estimated to value USD 6,685.0 million in 2021 and is projected to reach USD 10,448.8 million by 2030 with a CAGR of 5.1%. However, without the COVID-19 impact, high throughput screening segment was estimated to be USD 6,687.6 million in 2021 and reach USD 10,320.0 million by 2030 with a CAGR of 4.9%.

High throughput screening is widely used as a drug discovery process in pharmaceutical industry. It allows to quick assay of the biochemical or biological activity for several compounds. High throughput screening methods are used to accelerate target analysis with access to large-scale compound libraries cost-effectively. These tests are used to determine the drug design before the development of a potential drug. Therefore, increasing demand for new effective drugs against prevention and treatment for various diseases and conditions is expected to drive the segment growth during the forecast period.

Based on application, the market is segmented into cardiovascular diseases, Parkinson’s disease, Alzheimer’s disease, and others. The cardiovascular diseases segment is expected to hold the largest share in the global drug discovery technologies market during the forecast period. Cardiovascular diseases segment in the COVID-19 period has been estimated to value USD 13,962.6 million in 2021 and is projected to reach USD 21,684.0 million by 2030 with a CAGR of 5.0%. However, without the COVID-19 impact, cardiovascular diseases segment was estimated to be USD 13,968.1 million in 2021 and reach USD 21,416.7 million by 2030 with a CAGR of 4.9%.

Cardiovascular diseases include heart failure, heart attack, abnormal heart rhythms, and other related conditions and are the leading cause of death globally. Emerging cardiovascular drug development companies with increasing clinical trials are driving the segment growth. Furthermore, growing prevalence of disease and awareness of cardiovascular therapeutics are projected to have a significant impact on the market growth during the forecast period.

Based on end user, the market is segmented into biopharmaceutical companies, biotech companies, pharmaceutical companies, and research institutes. The biopharmaceutical companies’ segment is accounted to hold the largest share in global drug discovery technologies market during the forecast period. Biopharmaceutical companies’ segment in the COVID-19 period has been estimated to value USD 14,025.6 million in 2021 and is projected to reach USD 22,621.8 million by 2030 with a CAGR of 5.5%. However, without the COVID-19 impact, biopharmaceutical companies’ segment was estimated to be USD 14,031.1 million in 2021 and reach USD 22,342.9 million by 2030 with a CAGR of 5.3%.

Biopharmaceutical companies use the processes of living organisms as they discover drugs and develop medicines to provide treatments for untreated or undertreated medical conditions. Thus, growing research activities and venture fundings for discovering new target drugs are expected to fuel the market growth during the forecast period,

Based on region, the market has been segmented as North America, Europe, Asia Pacific, Middle East and Africa, and South America. North America is expected to be the largest region in the drug discovery technologies market during the forecast period. North American drug discovery technologies market in the COVID-19 period has been estimated a value of USD 11,595.1 million in 2021 and is projected to reach USD 18,618.5 million by 2030 at a CAGR of 5.4%. However, without the COVID-19 impact, North American drug discovery technologies market was estimated to be USD 11,599.6 million in 2021 and reach USD 18,389.0 million by 2030 with a CAGR of 5.3%.

The factor driving market growth in North America is the rapid technological advancements for drug discovery. Also, the presence of established players is predicted to play a significant role in strengthening the regional market. Moreover, growing prevalence of chronic diseases in the U.S. is the leading factor supporting the high demand for drug discovery technologies in the region.

However, Asia Pacific is expected to be the fastest growing region during the forecast period. Growing drug discovery & development research activities in developed countries like China, and the adoption of AI-based drug discovery technologies are expected to boost the Asia Pacific market during the forecast period.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bio-Rad Laboratories Inc.
  • Perkinelmer Inc. Incyte
  • Gyros Protein Technologies
  • Evotec
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Astrazeneca
  • F. Hoffmann- La Roche Ltd.
  • Merck Kgaa
  • Charles Laboratories International Inc.
  • Tecan
  • Shimadzu Corporation
  • Eurofins Scientific
  • Chembridge Corporation